What is Anixa Biosciences, Inc.'s Market Cap?

Anixa Biosciences, Inc.'s Market Cap is $96.6M, based on as-reported figures from SEC (XBRL) filings.

What is Anixa Biosciences, Inc.'s Enterprise Value?

Anixa Biosciences, Inc.'s Enterprise Value is $82.9M, based on as-reported figures from SEC (XBRL) filings.

What is Anixa Biosciences, Inc.'s Revenue (TTM)?

Anixa Biosciences, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Anixa Biosciences, Inc.'s Net Income (TTM)?

Anixa Biosciences, Inc.'s Net Income (TTM) is -$10.0M, based on as-reported figures from SEC (XBRL) filings.

What is Anixa Biosciences, Inc.'s Diluted EPS (TTM)?

Anixa Biosciences, Inc.'s Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.

What is Anixa Biosciences, Inc.'s Net Debt?

Anixa Biosciences, Inc.'s Net Debt is -$13.7M, based on as-reported figures from SEC (XBRL) filings.

Anixa Biosciences, Inc. (ANIX) Financial Statements

Anixa Biosciences, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5Q1P7

XNAS · usd

2.84▼ 0.06 (-2.07%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.90

Day's Range2.88 – 3.20

52-Week Range2.32 – 5.46

Volume439.7K

Avg Volume250.0K

Share Statistics

Shares Outstanding

Employees4

ExchangeXNAS

Listed1983-10-07

Share count as of June 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Anixa Biosciences, Inc. (ANIX)

What is Anixa Biosciences, Inc.'s Market Cap?: Anixa Biosciences, Inc.'s Market Cap is $96.6M, based on as-reported figures from SEC (XBRL) filings.
What is Anixa Biosciences, Inc.'s Enterprise Value?: Anixa Biosciences, Inc.'s Enterprise Value is $82.9M, based on as-reported figures from SEC (XBRL) filings.
What is Anixa Biosciences, Inc.'s Revenue (TTM)?: Anixa Biosciences, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Anixa Biosciences, Inc.'s Net Income (TTM)?: Anixa Biosciences, Inc.'s Net Income (TTM) is -$10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Anixa Biosciences, Inc.'s Diluted EPS (TTM)?: Anixa Biosciences, Inc.'s Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.
What is Anixa Biosciences, Inc.'s Net Debt?: Anixa Biosciences, Inc.'s Net Debt is -$13.7M, based on as-reported figures from SEC (XBRL) filings.